Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
Dipartimento di Scienze Biomediche Sperimentali e Cliniche "Mario Serio" - Università degli Studi di Firenze | Italy | 19 days ago
• Stem cell analysis in cancer • 2D and 2D complex in vitro cell and organoid cultures • Spatial and Liquid biopsy processing and analysis • Cell engineering • Bioinformatics and data analysis Where
-
stem cells or stem cell-based biomaterials? And eager to explore cutting-edge technologies like genome editing and in vivo imaging? Or are you perhaps fascinated by eye research and do you have an
-
, research is vital to advance diagnosis, treatment and prevention. Our strength is in identifying and designing novel therapeutic strategies that will lead to clinical trials. PhD: 3-4 years full-time; 5
-
mouse embryonic stem cells to allow for rapid protein depletion, mapping transcriptional effects (RNA-seq, TT-seq, PRO-seq), proximity labeling approaches, ChIP, and the bioinformatic analysis
-
, optogenetics, genome engineering, induced pluripotent stem cell differentiation to neurons/organoids, and in vitro and in vivo electrophysiological measurements. Our long-term scientific goal is to dissect
-
) or PhD (for PostDoc) in stem cell biology, developmental biology, biophysics, or related fields Strong expertise in pluripotent stem cell culture and differentiation protocols Practical experience with
-
nominations and applications is now open. We warmly invite exceptional fresh PhD graduates from institutions around the world to apply. To learn more about the Program, please visit https
-
? Other EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description The In vivo Organ Generation by Stem Cells Group, led by Dr. Xabier Aranguren is looking
-
organoid-based research. For more information go to: https://www.bauschlab.org Your Qualification: High motivation, curiosity, and commitment to scientific excellence PhD in stem cell biology, developmental
-
stem cell deficiency (LSCD), which leads to blindness and currently has no effective treatment options. The research group uses various transgenic and traumatic models of LSCD, and your responsibilities